Recombinant full length protein corresponding to Human VEGFA.
Our Abpromise guarantee covers the use of ab36424 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||Use a concentration of 2 - 10 µg/ml. Predicted molecular weight: 45 kDa.|
|ELISA||Use a concentration of 1 - 15 µg/ml.|
|Neutralising||Use at an assay dependent dilution. Has been shown to block the VEGFA induced proliferation of ACE cell at a 1:6 molar ratio of ligand to antibody. Inhibits the binding of VEGF A to the VEGF receptors 1 (Flt-1) and 2 (KDR).|
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"